GeneLink Receives Notice of Allowance of Patent On Its DNA Collection Kit.Business Editors MARGATE, N.J.--(BUSINESS WIRE)--March 19, 2001 GeneLink, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : GNLK), The World's First Family Centered DNA Bank and Hereditary Genetic Information Service, today announced that it has received a Notice of Allowance of a Patent of GeneLink's Non-Invasive DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. Collection Kit from the United States Department of Commerce The United States Department of Commerce is the Cabinet department of the United States government concerned with promoting economic growth. It was originally created as the United States Department of Commerce and Labor on February 14, 1903. , Patent and Trademark Office as of March 12, 2001. GeneLink's DNA Collection Kit offers the public a safe, easy, non-invasive method of collecting one's DNA and storing it for future reference at the Company's DNA Bank located at the University of North Texas Health Science Center at Fort Worth The school was chartered in 1966 as Texas College of Osteopathic Medicine, and its first class of students entered in 1970. TCOM signed an affiliation agreement with North Texas State University (now UNT) in 1972, and a state Senate bill passed in May 1975 made the institution a , Texas, a 105 year old medical facility. GeneLink allows families the opportunity to store their genes for generations, providing a genetic family history that can be useful in the healthcare treatment of certain inherited diseases. John R. DePhillipo, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of GeneLink, says, "We have been waiting for this patent for 3 years. The potential uses for GeneLink's DNA Collection Kit by a wide variety of industries is enormous. As genetics moves forward, pharmaceutical and genomic companies will need a safe, confidential and organized method of collecting large amounts of DNA for future studies of disease and the manufacturing of medicines to treat disease. We are extremely excited and proud about the issuance of this patent." Dr. Arthur Eisenberg, world expert on forensic genetics and Director of the DNA Identity Lab, at the University of North Texas Health Science Center (the location of the GeneLink DNA banking facility), says, "As genetics moves into the physicians office, GeneLink's DNA Collection Kit will provide a simple method for the collecting and transporting of a patient's sample for DNA analysis DNA analysis Any technique used to analyze genes and DNA. See Chromosome walking, DNA fingerprinting, Footprinting, In situ hybridization, Jeffries' probe, Jumping libraries, PCR, RFLP analysis, Southern blot hybridization. . GeneLink's DNA Collection Kit, with its triple bar-coded system, assures accurate and reliable sample processing." GeneLink will seek licensing for manufacturing and use of its DNA Collection Kit from pharmaceutical and medical institutions. Forward-Looking Statements: This news release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, which provides a new "safe harbor" for these types of statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion